← Back to headlines
Halozyme Therapeutics, Inc. Reports Q4 2025 Earnings
Halozyme Therapeutics, Inc. has released a summary of its fourth-quarter 2025 earnings call, detailing its financial performance.
18 Feb, 13:30 — 18 Feb, 13:30
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Investment Outlook: Dividend Aristocrats Poised for 2026 Rebound
17m ago
Stock Market Today, Feb. 20: CoreWeave Falls After Blue Owl Data Center Financing Failure Raises Funding Concerns
57m ago
Why CoreWeave Was Plunging To End the Week Today
57m ago
Costco Price Target Raised by Evercore ISI and Citi After Q2 Beat
57m ago